Fox, S., Generali, D., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Harris, A. (2011). The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Παραπομπή σε μορφή Chicago (17η εκδ.)Fox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.
Παραπομπή σε μορφή MLA (9th εκδ.)Fox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.